SEC seeks public input on stricter rules for foreign firms on U.S. markets, singles out ChinaJune 4, 2025
Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology Finance June 1, 2025 Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology Taiho Oncology…
